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INTRODUCTION:
We have carried out studies using high-field (9.4T) fMRI to mechanistically examine the effects of adjuvant chemotherapy commonly used for breast cancer treatment on brain function in a rat model. There is a growing literature demonstrating that adjuvant chemotherapy administration for breast cancer and other malignancies induces cognitive impairment in a significant proportion of patients [1] [2] [3] . This has often been referred to as chemobrain or chemofog. At present, little is known regarding its cause at a mechanistic level, or even its duration and/or permanence. Similarly, there are no generally accepted treatments to either prevent or ameliorate the cognitive effects of cancer chemotherapy. Rodent models for the study of the toxicity of doxorubicin and other chemotherapeutic agents have been developed and behavioral impairment has been demonstrated using them [4, 5] . It is the overall goal of this project to investigate this at a mechanistic level by determining the effects of doxorubicin, one of the agents commonly used for the adjuvant chemotherapy of breast cancer, on brain function using fMRI and behavioral techniques in a rat model. It is hoped that this model will enable us to ultimately determine the duration of and mechanism for the effects of doxorubicin on brain function and to ultimately evaluate the efficacy of possible neuroprotective or other agents in preventing or treating chemobrain.
BODY:
Effects of Doxorubicin (DOX) on brain activation by somatosensory and visual stimulation. We have carried out studies in female rats examining the effects of weekly treatment with doxorubicin on brain activation induced by somatosensory and visual stimulation. The methods are detailed below. Female control rats (225 g) and rats treated once a week (4 to 7 weeks) with 2.5 mg/kg iv of DOX were studied. In One week later they were prepared for imaging. Scanning was performed using our 30 cm, 9.4 T scanner. Rats were anesthetized with dexmedetomidine and artificially respirated after paralysis with pancuronium. It has been demonstrated at this institution that this paradigm allows for near normal heart rate, BP and blood gases and preserves brain fMRI response to sensory stimulation and functional connectivity [6, 7] . The adjacent figures shows the effects of three intensity levels of electrical stimulation of the forepaw (SS) on activation in the somatosensory cortex and flashing light stimulation (VIS) of the eye on activation in the superior colliculus. Figure 1 shows the regions that were significantly activated (corrected p<0.5) by the forepaw (a) and visual (b) stimulation along with representative activation patterns from 9 adjacent voxels in the region.
It can be seen that electrical stimulation of the forepaw produces strong intensity-related activation in the ipsilateral forelimb somatosensory cortex and in a small region of the striatum. Visual stimulation produced bilateral activation of the superior colliculus, lateral geniculate and a small region of activation in primary visual cortex. When mean activation intensity is computed in each anatomical region (Fig 2.) , it can be seen that both SS (A) and VIS (B) produce activation that increases parametrically with stimulus intensity in control rats. This is altered significantly (p≤ 0.05) by These results demonstrate the feasibility of using brain activation by parametric sensory stimulation as measured by BOLD fMRI as being sensitive to the effects of DOX administration and as an appropriate tool to determine the duration of effects and the ability of antioxidants and other drugs to modify DOX-induced effects. Effects of Doxorubicin on Global and Regional CBV and CBF Whole brain and functional region of interest (ROI) measurements of cerebral blood flow (CBF) and relative cerebral blood volume (rCBV) where made in the control and DOX treated rats reported on in figs. 2 and 3. after the completion of the resting state and sensory activation scans described above were completed. Briefly, for perfusion scanning, a set of pre-contrast images is acquired using a fast-spoiled gradient recalled echo (SPGR) sequence. Next, The perfusion scan is carried out with Multihance (0.1 mmole/kg) injected during the acquisition, followed by a post contrast scan. Image processing is described below. There was a slight but not significant 12% decrease in whole brain CBF which may been driven by significant (p≤ 0.05) decreases in both the right and left lateral geniculate functional ROIs (25% and 29%, respectively). There were smaller but not statistically significant decreases in the other visual system ROIs (superior colliculus and primary visual cortex). A similar pattern was also observed for rCBV with a significant 28% decrease in rCBV in the left lateral geniculate and a smaller (17%) non-significant decrease in the right lateral geniculate. These differences are interesting in view of the greater impairment of VIS stimulation-induced activation compared to SS-induced activation after DOX treatment. Since this is a resting state measurement, there are implications for the interpretation of BOLD fMRI measurement in these animals. If this holds true in future studies, we will need to account for the changes in perfusion in our calculation of task activation. Functional Connectivity (fcMRI) Studies. Functional connectivity (fC) studies have provided insight into the intrinsic functional architecture of the brain, variability in behavior, and potential physiological correlates of neurological and psychiatric diseases, and could give further insight into mechanisms underlying the effects of chemotherapeutic drugs on cognition. We examined resting state fcMRI in this pgroup of rats by performing a 6 min (A single-shot EPI sequence (FOV=3.5 cm, slice thickness 1 mm, image matrix = 96×96, zero filled to 128x128, TR=2000 ms, TE=19 ms, TR = 2000 ms) resting state scan prior to any sensory stimulation. Three functional seed ROIs were defined based on the group SS and VIS fMRI data. The functional ROIs were from within the right forelimb somatosensory and the right and the left superior colliculus cortex. Mean time-course signal from each ROI was then used as a regressor of interest to isolate regions that are functionally correlated. One-sample t-tests were performed and results are shown In figure 3 A two sample t-test was done to then compare the groups. All group maps are thresholded at p<0.05. It can be seen in Figure 3A that that there is significant correlation between resting state MR signal There were few regions that were consistently significantly different between the two groups. However, in ROIs associated with the visual system, significant decreases in resting state functional connectivity were observed in the DOX group. The right superior colliculus (involved in visual system reflexes, etc.) is the seed region in 3B and the left in 3C. There was widespread functional connectivity between the seed regions and bilateral visual cortex in the control group. There is significantly diminished connectivity between seed ROI and cortex in the DOX group when compared to the control group. This is consistent with our finding above of diminished activation by visual stimulation in the DOX group. This supports our hypothesis that treatment with DOX will cause changes in neuronal functional activity that can be detected and quantified using fMRI methods. Furthermore, it is consistent with impaired visual cognitive processing reported after chemotherapy [8] .
Effects of DOX on rotarod and novel object test behavior. The effects of the above DOX treatment on performance in the rotarod test and novel object tests were also examined. the rotarod test of motor skill learning is sensitive to motor skill learning and not just general levels of fitness Since skill learning is typically associated with the cerebellum and motor pathways, and human studies of PET imaging in chemobrain have reported changes in blood flow in these regions [9] , this task may be sensitive to the effects of chemotherapy agents on brain regions involved in locomotor activity and motor skill learning. Animals are placed on the rotarod and receive 10 consecutive training sessions as the rod rotates at 10 rpm. The novel object recognition test measures recognition memory through novel object orientation in rats [10] . According to the paradigm, the test is conducted in an open field containing objects constructed with Duplo Lego blocks placed in 4 distinct locations spaced evenly in a circular field. A habituation, sample trial, and choice trial session occur. During habituation, animals are allowed to explore 2 identical cubes for 15 minutes. During the sample trial, rats are allowed to explore 2 new objects for 5 minutes. Following a delay, animals perform the choice trial. During the choice trial, animals are allowed to explore a novel object and a familiar (previously explored) object for 5 minutes. The dependent measure is amount of time exploring. Object location remains consistent during learning sessions. Behavioral testing is carried out one day prior to scanning. Control rats remained on the rotarod for 124±10 seconds. This was reduced by 31.5% to 85±11 sec in the DOX treated group. In the novel object test, control rats spent 57% more time exploring the novel object compared to the familiar object. This was not seen in the DOX treated group. In addition, the control group traveled an increased distance during the sessions. (They averaged 2325±242 cm compared to 1748±95 cm for the DOX group.) These suggests that the proposed measures are sensitive to the effects of DOX. However we must take differences in general motor activity into account in interpretation of the results.
KEY RESEARCH ACCOMPLISHMENTS:
We have demonstrated in a rat model of DOX toxicity:
• DOX treatment alters brain activation by sensory stimulation particularly in regions associated with visual systems.
•
Resting state functional connectivity MRI is quantifiable in the dexmedetomidine anesthetized rat and that functional connectivity is decreased by DOX treatment, particularly in the visual system.
We consistently see functional impairment in the visual system compared to the somatosensory system in the rat. Although this is not one of the most commonly reported symptoms of human "chemobrain", it is consistent with impaired visual cognitive processing reported after chemotherapy [8] . This may give us a tool that is needed to compare other indicators of DOX toxicity, such as oxidative stress in the two systems REPORTABLE OUTCOMES: During this single year project we have submitted 3 abstracts, made 2 presentations at national meetingsand will be making a third this summer. We have also used the data gathered from this Concept award as preliminary pilot data for the submission of program project grant to the NCI. the title of the proposal is "New Paradigms for Breast Cancer Therapy Optimized with Advanced Imaging". The project associated with this award is "Effects of Doxorubicin on Brain Activity in Rats: Functional Imaging Studies" It received the best score of the study section that reviewed it, and we are awaiting a funding decision. The research conducted under this Concept Award demonstrates the feasibility of using a rat model to study the effects of cancer chemotherapy on brain function and behavior. To date we have found that treatment with the anthracyciline cancer chemotherapy agent, doxorubicin alters brain activation by sensory stimulation particularly in regions associated with visual systems. We have also demonstrated thatesting state functional connectivity MRI is quantifiable in the dexmedetomidine anesthetized rat and that functional connectivity is decreased by DOX treatment, particularly in the visual system. We consistently see functional impairment in the visual system compared to the somatosensory system in the rat. Although impairment in the visual system is not one of the most commonly reported symptoms of human "chemobrain", it is consistent with impaired visual cognitive processing reported after chemotherapy. These results demonstrate the feasibility of using brain activation by parametric sensory stimulation and resting-state functional connectivity as measured by BOLD fMRI as being sensitive to the effects of doxorubicin administration and hopefully that of other cancer chemotherapy agents as an appropriate tool to determine drug mechanisms and the ability of antioxidants and other drugs to modify chemotherapyinduced cognitive effects. Figure 2A that that there is significant correlation between resting state MR signal patterns in the FSSC seed area and both the surrounding cortex and thã contralateral FSSC. There were no regions that were consistently significantly different between the two groups. However, in ROls associated with the visual system, signifìcant decreases in resting state functional connectivity were observed in the DOX group. The right SC is the seed region in 2B and the left in 2C. There is functional connectivity between the seed regions and bilateral PVC in the control group. This is signífìcantly diminished in the DOX group. This ìs consistent with our finding in of diminished activat¡on by visual st¡mulat¡on, in the DOX group This supports our hypothesis that treatment witir DOXwill cause changes in neuronal functional activ¡ty thai can be detected and quantified using fMRl and resting state fcMRl methods ffi* fiÇr ffir
